NCT05082909View on ClinicalTrials.gov

Addition of Probenecid to Penicillin-V Therapy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 21, 2021

Primary Completion Date

July 7, 2022

Study Completion Date

July 7, 2022

Conditions
Infection, Bacterial
Interventions
DRUG

Probenecid

Addition of 500mg QDS to oral penicillin.

Trial Locations (1)

Unknown

Imperial Clinical Research Facility, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT05082909 - Addition of Probenecid to Penicillin-V Therapy | Biotech Hunter | Biotech Hunter